HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Bruno Lomonte Selected Research

Snake Venoms (Snake Venom)

11/2014Intravascular hemolysis induced by the venom of the Eastern coral snake, Micrurus fulvius, in a mouse model: identification of directly hemolytic phospholipases A2.
9/2012Snake venom Lys49 myotoxins: From phospholipases A(2) to non-enzymatic membrane disruptors.
7/2011Membrane cholesterol modulates the cytolytic mechanism of myotoxin II, a Lys49 phospholipase A2 homologue from the venom of Bothrops asper.
3/2008Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: comparison of high- and low-molecular weight fractions.
2/2008Snake venomics of Central American pitvipers: clues for rationalizing the distinct envenomation profiles of Atropoides nummifer and Atropoides picadoi.
3/2007Antitumor effects of cationic synthetic peptides derived from Lys49 phospholipase A2 homologues of snake venoms.
4/2005A Lys49 phospholipase A(2) homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line.
12/2002Functional analysis of DM64, an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Bruno Lomonte Research Topics

Disease

18Snake Bites (Snake Bite)
01/2015 - 01/2005
11Necrosis
01/2013 - 08/2002
9Edema
01/2015 - 07/2004
3Hemorrhage
01/2015 - 12/2002
3Pain (Aches)
01/2013 - 08/2002
2Hemolysis
11/2014 - 03/2007
2Rhabdomyolysis
01/2012 - 12/2011
2Bites and Stings (Sting)
01/2005 - 01/2003
1Melanoma (Melanoma, Malignant)
12/2014
1Inflammation
01/2013
1Body Weight (Weight, Body)
10/2012
1Gangrene
11/2011
1Contagious Ecthyma (Orf)
01/2011
1Sarcoma (Soft Tissue Sarcoma)
03/2007
1Experimental Melanoma
03/2007
1Neoplasms (Cancer)
03/2007
1Carcinoma (Carcinomatosis)
03/2007
1African Trypanosomiasis (Nagana)
07/2005
1Onchocerciasis
07/2005
1Infection
04/2005
1Ischemia
08/2002

Drug/Important Bio-Agent (IBA)

19VenomsIBA
01/2015 - 08/2002
10Antivenins (Antivenoms)IBA
06/2014 - 01/2003
8Snake Venoms (Snake Venom)IBA
11/2014 - 12/2002
5Phospholipases (Phospholipase)IBA
08/2010 - 04/2005
4Phospholipases A2 (Phospholipase A2)IBA
11/2014 - 07/2005
3AntibodiesIBA
12/2009 - 03/2007
2fucoidanIBA
03/2008 - 01/2008
2PeptidesIBA
03/2007 - 04/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015
1Fibronectins (Fibronectin)IBA
12/2014
1VitronectinIBA
12/2014
1DisintegrinsIBA
12/2014
1Extracellular Matrix ProteinsIBA
12/2014
1Collagen Type I (Type I Collagen)IBA
12/2014
1Laminin (Merosin)IBA
12/2014
1Creatine Kinase (Creatine Phosphokinase)IBA
09/2013
1EnzymesIBA
02/2013
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2012
1CrotoxinIBA
12/2011
1Proteins (Proteins, Gene)IBA
01/2011
1PotassiumIBA
08/2010
1Adenosine Triphosphate (ATP)IBA
08/2010
1Immunoglobulins (Immunoglobulin)IBA
11/2008
1Propidium (Propidium Iodide)IBA
01/2008
1Paclitaxel (Taxol)FDA LinkGeneric
03/2007
1Immunoglobulin G (IgG)IBA
09/2006
1polyanionsIBA
07/2005
1Suramin (Suramin Sodium)IBA
07/2005
1Heparin (Liquaemin)FDA LinkGeneric
07/2005
1Interleukin-6 (Interleukin 6)IBA
07/2004
1Phospholipases AIBA
11/2003
1FibrinIBA
08/2002
1Fish VenomsIBA
08/2002

Therapy/Procedure

1Subcutaneous Injections
04/2007